A 62-year-old woman with a history of hypertension and diabetes presents to the emergency department with acute chest pain and dyspnoea for 1.5 hours. On examination, she is pale, diaphoretic, and has a blood pressure of 88/56 mmHg with a heart rate of 118/min. Lung auscultation reveals bilateral crackles. Her 12-lead ECG shows ST elevation of 4 mm in leads V1–V4 with reciprocal ST depression in leads II, III, and aVF. Troponin I is 3.2 ng/mL. A bedside echocardiogram shows severe hypokinesis of the anterior and anteroseptal wall with an ejection fraction of 28%. What is the most appropriate next step in management?

Explanation

## Clinical Presentation: Anterior STEMI with Cardiogenic Shock **Key Point:** This patient has acute anterior wall STEMI complicated by cardiogenic shock (hypotension, tachycardia, pulmonary oedema, reduced ejection fraction). This is a high-risk presentation requiring urgent revascularization. ## Diagnostic Features | Finding | Significance | |---------|-------------| | ST elevation V1–V4 | Anterior wall STEMI (LAD territory) | | Hypotension (88/56) + tachycardia | Cardiogenic shock | | Bilateral crackles | Pulmonary oedema (LV failure) | | EF 28% | Severe systolic dysfunction | | Elevated troponin | Myocardial necrosis confirmed | ## Why Primary PCI is Mandatory **High-Yield:** In STEMI with cardiogenic shock, primary PCI is the gold standard reperfusion strategy. Thrombolysis has been shown to be inferior in this subset (SHOCK trial). **Mnemonic: SHOCK Trial Lesson — **S**urgical/percutaneous revascularization, **H**igh-risk STEMI, **O**utcome improved, **C**ardiogenic shock, **K**ey: PCI > thrombolysis** ## Management Algorithm ```mermaid flowchart TD A[Anterior STEMI + Cardiogenic Shock]:::outcome --> B{PCI-capable centre available?}:::decision B -->|Yes, <120 min| C[Immediate Primary PCI]:::action B -->|No| D[Consider thrombolysis + transfer]:::action C --> E{Haemodynamic support needed?}:::decision E -->|Yes| F[IABP or mechanical support]:::action E -->|No| G[Standard PCI + dual antiplatelet]:::action F --> G G --> H[Intensive post-PCI monitoring]:::action D --> I[Thrombolysis door-to-needle <30 min]:::action ``` ## Mechanical Support Considerations **Clinical Pearl:** In cardiogenic shock from acute MI, intra-aortic balloon pump (IABP) can: - Reduce afterload (improves cardiac output) - Augment diastolic pressure (improves coronary perfusion) - Bridge to PCI or definitive therapy **Warning:** Do NOT use vasodilators (nitrates) as monotherapy in cardiogenic shock — they worsen hypotension. Nitrates are adjunctive only after haemodynamic stabilization. ## Why NOT Thrombolysis? 1. **SHOCK Trial (1999):** Showed PCI superior to thrombolysis in cardiogenic shock (30-day mortality: 46.7% thrombolysis vs. 38.6% PCI) 2. **Anterior STEMI:** Higher risk of mechanical complications (rupture, VSD); needs angiographic assessment 3. **Haemodynamic instability:** Thrombolysis may worsen shock; PCI allows direct assessment and mechanical support ## Inotropes: Adjunctive Only **Key Point:** Dobutamine or milrinone are temporizing measures, not definitive therapy. They increase myocardial oxygen demand and may worsen ischaemia if coronary flow is not restored. Revascularization must be the priority.